Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Toby Lipman a Westerhope Medical
Group, Newcastle upon Tyne NE5 2LH, b Blyth Valley Primary Care
Group, Blyth, Northumberland NE24 2JN
Correspondence to: T Lipman toby{at}tobylipm.demon.co.uk
| |
Abstract |
|---|
|
|
|---|
Objectives:
To describe a group general practice's
implementation of a decision to prescribe 3 day courses of 200 mg
trimethoprim twice daily for urinary tract infections in women and to
compare 3 day courses with 5 and 7 day courses.
Successful programmes for implementing effective healthcare
interventions have often developed from projects on single topics that
have been carried out in local areas but organised outside individual
general practices.1 Of necessity these programmes address
only one aspect of health care at a time, yet practices need
continuously to re-examine their policies on many topics if they want
to improve clinical effectiveness and cost effectiveness. It is
unrealistic to expect large scale projects to be implemented to assess
each aspect of health care, therefore practices must rely on their own
resources to make decisions about most changes in clinical management.
Westerhope Medical Group benefited from the services of a qualified
pharmacist (DP) for one session per week who facilitated this process.
She presented reports on the practice's prescribing patterns and made
recommendations based on local policy and evidence selected by local
experts. Until the events described in this paper decisions about
changes in prescribing were made at meetings of the practice's
partners (which she attended), taking into account her reports and advice.
At one meeting we decided to use 3 day courses of trimethoprim
(200 mg twice daily) as the first line treatment for uncomplicated lower urinary tract infection occurring in adult women. Evidence from
local experts supported this regimen.2 The partners did not critically appraise the evidence before implementing the decision; it was made by consensus after a brief discussion.
More than a year later, soon after we had introduced fortnightly
multidisciplinary educational sessions,3 a practice nurse claimed, during a session devoted to questions from everyday practice, that the change to the 3 day course had led to more treatment failures.
At that point some general practitioners claimed not to have heard of
the new policy, and we realised that it was not being implemented consistently.
We decided to obtain and critically appraise the articles cited in
support of the policy and to search for new evidence. At the same time
we would also audit the prescribing of trimethoprim for urinary tract
infections and the investigations and second visits associated with its
use. Merely returning for a second visit does not necessarily indicate
that a treatment has failed but was a practicable outcome measure given
that patients in routine clinical practice are not likely to be
followed up as systematically as in clinical trials. However, we felt
that we would be justified in reviewing our policy if the audit found
that there was a significantly higher rate of reconsultation among
patients who had been given 3 day courses of trimethoprim compared with
those who had been given 5 or 7 day courses.
Critical appraisal
Literature search
Audit
Critical appraisal and literature search
Table 1.
Design:
Record review, audit of trimethoprim
prescribing for urinary tract infections, and critical appraisal of
evidence originally presented in support of 3 day course.
Setting:
Group general practice in Newcastle upon Tyne.
Data sources:
The records of all female patients aged
12 years and older who were prescribed trimethoprim for uncomplicated urinary tract infections during a 12 month period were reviewed. 271 valid records were identified.
Data extraction:
Prescribing rates for different
courses of trimethoprim, rates of patients returning for second
consultations, rates of urine cultures, results of cultures, results of
critical appraisal of evidence.
Results:
114 of 271 (42%) prescriptions written at the first visit were for 3 day courses. 16 of 114 (14%) patients who
had had a 3 day course of treatment returned for a second consultation
compared with 6/83 (7.2%) of those who had had a 5 day course and 8/74
(11%) who had had a 7 day course. The difference between 3 day and 5 day courses in rates of returning for second consultations was 6.8%
(95% CI
1.7% to 12.6%) and between 3 day and 7 day courses was
3.2% (
3.6% to 10.0%). Appraisal of the original evidence on which
the practice based its recommendations showed that it was flawed.
Additional evidence was found in the Cochrane Library.
Conclusions:
Our original decision, made by consensus
at a meeting of the practice's partners, had not led to a consistent change in practice. We did not find a significant increase in treatment
failures among patients treated with the 3 day regimen.
![]()
Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References
![]()
Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References
Copies of all the articles cited were obtained and
critically appraised using checklists from standard
texts.4-9 Critical appraisal took less than an hour, and
most articles did not meet the essential criteria given in the
checklists which would have allowed them to be classed as
methodologically rigorous studies.
A 10 minute search of the Cochrane Library found
a meta-analysis of randomised trials of single dose treatment with
antibiotics, randomised trials of 3 day courses of co-trimoxazole compared with 7 day courses for urinary tract infections in women, 3 day courses of co-trimoxazole and pivmecillinam compared with 10 day
courses, treatment with a single dose of an antibiotic compared with 3 day and 7 day courses (including a single dose of co-trimoxazole
compared with a 3 day course), and treatment with 3 days of
co-trimoxazole compared with 10 days.10-14
Electronic medical records were searched by DP to identify
all prescriptions for trimethoprim written in the 12 months after the
decision had been made to use a 3 day course as first line treatment.
The records of children younger than 12 years were excluded. Both the
paper and the electronic records were retrieved and examined. The
length of the first prescription for trimethoprim in days (3, 5, or 7)
was recorded, whether the patient returned with similar symptoms within
2 weeks, whether a urine culture was performed at the time of the first
or second consultation, the result of the culture (no growth, sensitive to trimethoprim, sensitive to other antibiotic), the sex of the patient, and the general practitioner who wrote the prescription.
![]()
Results
Top
Abstract
Introduction
Methods
Results
Discussion
References
Four reviews were cited and their critical appraisals are
summarised in table 1.6-9 None is a full systematic review: no details are given of search strategies and only one outlines
the criteria used to evaluate the quality of trials (which are
described as modest) for inclusion in the review.8 The other reviews are expert reviews which cannot be relied
on.
6 7 9 15
|
Audit
Altogether, 302 prescriptions of trimethoprim written for
symptoms of urinary tract infections were identified. Thirty one
records were incomplete or missing or the patients had complex problems
such as an indwelling catheter or pyelonephritis; these records were
not included in the audit, leaving 271 records for analysis (table
3).
|
|
| |
Discussion |
|---|
|
|
|---|
Although these results are reassuring in that 3 day courses of trimethoprim for uncomplicated lower urinary tract infections do not seem to increase the rate of treatment failure, they raise a number of important issues.
Quality of evidence
Firstly, we were disappointed by the quality of the
evidence offered by apparently authoritative sources. The evidence
cited to support the use of a 3 day course of trimethoprim was scanty,
and using Eccles et al's classification, was rated category C at best:
it was based on extrapolated evidence from randomised controlled trials
(which were of mediocre quality).23 The only way to be
sure that 3 day courses of trimethoprim are as effective as 5 or 7 day
courses would be if results from well designed randomised controlled
trials in general practice were available; however, such trials have
yet to be carried out.
Uncertainty and compromise
Secondly, given that the quality of the evidence was poor,
would we make the same decision now given the same circumstances? It
was easy to find evidence in the Cochrane Library suggesting that 3 day courses of co-trimoxazole are as effective as longer courses, that trimethoprim alone is as effective as
co-trimoxazole,12 that the recommendation is supported by
expert consensus, and that it has biological plausibility. In the real
world we have to accept compromises and, despite a degree of
uncertainty, would probably have made the same decision. In future we
would question any recommendation or guideline and, at the very least,
assess its validity by critically appraising it before agreeing to
implement it.
Dissemination and implementation
Thirdly, even in a practice that was well motivated enough
to employ a pharmaceutical adviser and that had an explicit policy of
reviewing its prescribing, the original decision was not well
disseminated and only partially implemented. All of the general
practitioners prescribed courses of 3, 5, and 7 days even though they
had been party to and supportive of the original decision. In general
practice doctors deal with hundreds of different problems in a short
time and are not likely to remember every guideline or regimen for each
condition that they treat.24 Implementation of practice
policies requires reinforcement using strategies such as computerised
reminders, having regularly revised loose leaf practice manuals at each
desk, and providing educational activities within the practice. At an
educational session after the audit, the team used our findings to
produce a practice guideline which is based both on the best external
evidence (including evidence about diagnosis )25 and the
audit described here (box). Copies have been distributed to each team
member and placed at the telephone triage desk, and the audit will be
repeated in 12 months.
|
What is already known on this topic
For urinary tract infections in adult women some guidelines recommend 3 days of treatment with 200 mg trimethoprim twice daily, although there is some dispute over the most effective treatment Practices need continuously to re-examine their policies on many aspects of care if they want to improve clinical effectiveness and cost effectiveness What this study addsAn audit of outcomes at our surgery found no significant difference between women treated with the 3 day regimen and those treated with 5 or 7 day regimens A more critical appraisal of the evidence on which the guideline for a 3 day course of treatment was based showed that much of the evidence was flawed A small group educational process was more effective for making and implementing decisions in our practice than the administrative process of the partners' meeting |
|
Guidelines for treatment of urinary tract infections (developed by Westerhope Medical Group, June 1999) These guidelines apply only to adult women (older than 12 years) who have uncomplicated lower urinary tract infections. Diagnosis Diagnosis should be made if there is a history of urinary frequency and dysuria in the woman, if there is no suspicion of more serious problems (for example, pyelonephritis), and if the woman has no history of recurrent urinary tract infections (more than two in six months or three times in one year) Dipsticks are not reliable in the practice setting Analysis of a mid-stream urine specimen is not necessary for initial diagnosis Appointments Patients with a simple history may be treated without being seen Patients should be offered an appointment, and a mid-stream urine specimen should be sent for analysis before treatment if they present with a complex history Treatment First line treatment is 200 mg trimethoprim twice daily for 3 days A second course of treatment should be offered only if the first line treatment has failed, and it should be started after a mid-stream urine specimen has been sent for culture and sensitivity testing Information for patients If the symptoms have not resolved after 3 days of treatment with trimethoprim patients should make an appointment through the triage system and bring a mid-stream urine specimen in a plain urine container. The specimen should be sent as soon as possible but can be stored overnight in the refrigerator |
Conclusions
Clinical audit is now firmly established as a key
quality assurance method and our experience shows its value in
answering the question "are we doing what we're supposed to be
doing?" and "what is the effect of what we're
doing?"26 It is important that general practitioners
identify and address relevant questions and implement changes according
to the best evidence available. We have described the often messy and
uncoordinated process whereby we have tried to improve our practice. We
are always busy, always have to get through the next surgery, and struggle to find time and effective ways to evaluate and improve our
performance. Decisions must be made quickly using the best evidence and
data, and we must often trade methodological rigour for practicability
and speed. Making this particular decision in a partners' meeting
based on external advice did not lead to a consistent change in
practice. However, we were able to use multidisciplinary educational
methods in a small group to identify and address an important question.
Active educational methods in the practice setting are more effective
in achieving a sustained change in practice than passive methods (such
as lectures or dissemination of information on
paper).27 The small group educational process worked
better for us than the administrative process of the partners' meeting. It is now therefore our preferred method of identifying the
need for review or change in our practice, examining the evidence, and addressing the details of implementation.
| |
Acknowledgments |
|---|
Contributors: TL carried out the critical appraisal, searched for new evidence, calculated the statistics, and wrote the text. TL will act as guarantor for the paper. DP obtained the original articles for critical appraisal, carried out the audit, and collated the figures.
| |
Footnotes |
|---|
Funding: None.
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. | Dunning M, Abi-Aad G, Gilbert D, Hutton H, Brown C. Experience, evidence and everyday practice: creating systems for delivering effective health care. London: King's Fund, 1999. |
| 2. | The treatment of uncomplicated lower urinary tract infection. NHS Northern and Yorkshire Regional Drug and Therapeutics Newsletter 1994; 5: 17-18. |
| 3. | Lipman T. Structure and process before outcome: evidence-based learning in the primary health care team. In: Hungin APS, ed. Royal College of General Practitioners and NoReN annual research presentation days: abstracts of presentations and posters. Eaglescliffe: Northern Primary Care Research Network, 1998. |
| 4. | Greenhalgh T. How to read a paper: the basics of evidence-based medicine. London: BMJ Publishing, 1997. |
| 5. | Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine: how to practice and teach EBM. London: Churchill Livingstone, 1997. |
| 6. | Bailey RR. Management of lower urinary tract infections. Drugs 1993; 45(suppl 3): 139-144. |
| 7. | Neu HC. Urinary tract infections. Am J Med 1992; 92(suppl 4A): 63-70S. |
| 8. | Norrby SR. Short-term treatment of uncomplicated lower urinary tract infection in women. Rev Infect Dis 1990; 12: 458-467[Medline]. |
| 9. | Powers RD. New directions in the diagnosis and therapy of urinary tract infections. Am J Obstet Gynecol 1991; 164(5 Pt 2): 1387-1389[Medline]. |
| 10. |
Leibovici L, Wysenbeek AJ.
Single-dose antibiotic treatment for symptomatic urinary tract infections in women: a meta-analysis of randomized trials.
Q J Med
1991;
78:
43-57 |
| 11. | Trienekens TA, Stobberingh EE, Winkens RA, Houben AW. Different lengths of treatment with co-trimoxazole for acute uncomplicated urinary tract infections in women. BMJ 1989; 299: 1319-1322. |
| 12. | Gordin A, Kalima S, Makela P, Antikainen R. Comparison of three- and ten-day regimens with a sulfadiazine-trimethoprim combination and pivmecillinam in acute lower urinary tract infections. Scand J Infect Dis 1987; 19: 97-102[Medline]. |
| 13. | Greenberg RN, Reilly PM, Luppen KL, Weinandt WJ, Ellington LL, Bollinger MR. Randomized study of single-dose, three-day, and seven-day treatment of cystitis in women. J Infect Dis 1986; 153: 277-282[Medline]. |
| 14. | Fair WR, Crane DB, Peterson LJ, Dahmer C, Tague B, Amos W. Three-day treatment of urinary tract infections. J Urol 1980; 123: 717-721[Medline]. |
| 15. | Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 2nd ed. Boston: Little Brown, 1991. |
| 16. |
Co-trimoxazole use restricted.
Drug Ther Bull
1995;
33:
92-93 |
| 17. | Brumfitt W, Hamilton-Miller JM. Combinations of sulphonamides with diaminopyrimidines: how, when and why? J Chemother 1995; 7: 136-139[Medline]. |
| 18. | Iravani A. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Am J Med 1993; 94(suppl 3A): 89-96S. |
| 19. | Osterberg E, Aberg H, Hallander HO, Kallner A, Lundin A. Efficacy of single-dose versus seven-day trimethoprim treatment of cystitis in women: a randomized double-blind study. J Infect Dis 1990; 161: 942-947[Medline]. |
| 20. |
Saginur R, Nicolle LE.
Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women: Canadian Infectious Diseases Society Clinical Trials Study Group.
Arch Intern Med
1992;
152:
1233-1237 |
| 21. | Elwood M. Critical appraisal of epidemiological studies and clinical trials. 2nd ed. Oxford: Oxford University Press, 1998. |
| 22. |
Managing urinary tract infection in women.
Drug Ther Bull
1998;
36:
30-32 |
| 23. |
Eccles M, Clapp Z, Grimshaw J, Adams PC, Higgins B, Purves I, et al.
North of England evidence based guidelines development project: methods of guideline development.
BMJ
1996;
312:
760-762 |
| 24. |
Lipman T.
Discrepancies exist between general practitioners' clinical work and a guidelines implementation programme.
BMJ
1998;
317:
604 |
| 25. |
Winkens RA, Leffers P, Trienekens TA, Stobberingh EE.
The validity of urine examination for urinary tract infections in daily practice.
Fam Pract
1995;
12:
290-293 |
| 26. | Houghton G. From audit to effectiveness: an historical evaluation of the changing role of medical audit advisory groups. J Eval Clin Pract 1997; 3: 245-253[CrossRef][Medline]. |
| 27. |
Onion CW, Bartzokas CA.
Changing attitudes to infection management in primary care: a controlled trial of active versus passive guideline implementation strategies.
Fam Pract
1998;
15:
99-104 |
(Accepted 7 December 1999)
Trisha Greenhalgh Unit for Evidence Based
Practice and Policy, Department of Primary Care and Population
Sciences, Royal Free and University College Medical Schools, London N19
3UA
This paper is engaging for the story it tells. Once upon a
time there was an enthusiast, and this is what befell him. The evidence
itself is unremarkable Downing has argued that the process of change necessarily centres on
human characters whose moves are interpreted, told, and retold by
others within and outside the organisation.1 Human behaviour is driven by feelings, and stories of organisational change
tend to follow one of four basic plots: romance (the hero-adventurer meets and overcomes a series of challenges to earn his ultimate reward), tragedy (the hero works hard for a just cause but is pitched
from success to danger and ultimate humiliation), melodrama (a
polarised struggle between hero and villain, often with a climactic battle towards the end) and irony (the hero is exposed as incompetent, corrupt or a fool; the heroic actions are reinterpreted as a
scam).2
Most published accounts of implementing evidence based practice are
presented as teamwork-romance ("we pulled together, worked hard In this basic storyline, the hard liners for the evidence based agenda
come to discover that their academic value system The story of implementing best evidence in Lipman's practice is as yet
unfinished. We are left on a cliffhanger in which our humbled hero (or,
perhaps, the heroic dyad of GP-enthusiast and complicit pharmacist)
have sensibly abandoned their efforts to table clinical epidemiology as
"any other business" in administrative meetings. They have revised
their claims for the invincibility of research evidence and (we
suspect) have put in work backstage to muster support for the idea of
multidisciplinary practice education. The stage is set for real
progress. Watch out for the next exciting instalment.
The importance of exploring different value systems when
identifying barriers to change was suggested by Dr Charlotte Humphrey in relation to another project.
Competing interests: None declared.
indeed, one of the twists in the tale is that
it is found to be flawed
but if you kept reading till the bitter end,
it was probably to discover the fate of the brave pioneer who embarked
on a crusade of implementation in a practice where (we infer) the
language of evidence based health care was not universally spoken.
and
look what we've produced"), resource-tragedy ("we did our best but
were beaten by constraints [usually financial] beyond our
control"), or political melodrama ("key stakeholders had too much
to lose and blocked our efforts").
3 4
Lipman and
Price's story follows what is probably the commonest but least
publicised plot of all: the irony of misplaced values.
with its emphasis on
experiment, rigour, precision, and reproducibility
serves them poorly
in the untidy and unpredictable environment of service delivery.
Furthermore, the value system espoused by their service colleagues
with its emphasis on using available data and information systems, maintaining harmony and job fulfilment among staff, responding flexibly to individual needs, and keeping the customer satisfied
may be better able to initiate and sustain positive changes within the organisation.
![]()
References
1.
Downing SJ.
Learning the plot: emotional momentum in search of dramatic logic.
Management Learning
1997;
28:
27-44[Abstract].
2.
Gorman P.
Managing multidisciplinary teams in the NHS.
London: Kogan Page, 1998.
3.
Dunning M, Abi-Aad G, Gilbert D, Hutton H, Brown C.
Experience, evidence, and everyday practice: creating systems for delivering effective health care.
London: King's Fund, 1999.
4.
Evans D, Haines A. Evidence, effectiveness and the
experience of implementation: working to achieve evidence based changes
in the real world. Oxford: Radcliffe Publications, (in
press).
![]()
Acknowledgments
![]()
Footnotes
© BMJ 2000
Read all Rapid Responses